Infleqtion has completed its previously announced business combination with Churchill Capital Corp X, positioning the company to become the first publicly listed neutral-atom quantum technology company.
The transaction marks Infleqtion’s transition to the public markets. Following the closing, Churchill Capital Corp X has delisted its shares of common stock, warrants, and units from The Nasdaq Stock Market LLC. Shares of common stock and warrants of the combined company, Infleqtion, Inc., are expected to begin trading on the New York Stock Exchange beginning February 17, 2026, under the ticker symbols “INFQ” and “INFQ WS,” respectively. The units previously sold by Churchill X in its initial public offering have separated and are no longer listed on Nasdaq following the deal’s completion.
Infleqtion focuses on translating quantum technology into commercial and government-ready solutions designed to expand human potential. The company designs, builds, and sells quantum computers, precision sensors, and software to governments, enterprises, and research institutions worldwide.
As an early mover in neutral-atom technology, a quantum modality recognized for scalability, flexibility, and cost efficiency, Infleqtion has developed a unified commercial platform that supports both quantum computing and precision sensing from a single product architecture. Its portfolio includes quantum computers, quantum clocks, RF receivers, and inertial sensors, all optimized by proprietary software for real-world deployment.
Infleqtion collaborates with NVIDIA Corporation and counts customers such as the United States Department of War, National Aeronautics and Space Administration, and the Government of the United Kingdom among its users.
With the public listing, Infleqtion says it will become the only publicly traded company with commercial leadership spanning both quantum computing and precision sensing, further differentiating itself in the emerging quantum technology sector.
Infleqtion had previously announced in September 2025 its plans to go public through a merger with Churchill Capital Corp X. The completion of the business combination formalizes that plan and establishes the company’s presence on the NYSE as it seeks to scale its neutral-atom quantum platform globally.
